As previously reported, Wells Fargo analyst Stan Berenshteyn upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $41, up from $19, after a Q2 beat. Doximity’s ability to benefit from upsells seems stronger than suggested by survey and channel checks, according to the firm, which also thinks fiscal Q3 could see persistence of the tailwinds seen in Q2, making it “difficult to build a case for underperformance.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS: